Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-18

Clinical Trial Update: Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome(MET STUDY) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of Yangxinshi Tablet on exercise tolerance in patients with chronic coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yangxinshi Tablet

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Chronic Coronary Syndrome | Phase 4 | Status: UNKNOWN